Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

Selectively Replicating Adenoviruses for Oncolytic Therapy

Volume:1   Issue:2
Pp: 85-107
Tack-Kee Laurent Yoon, Toshiaki Shichinohe, Sylvie Laquerre and Noriyuki Kasahara
DOI: 10.2174/1568009013334223

Order Reprints Order Eprints

Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations

Volume:1   Issue:2
Pp: 109-119
A. Rodriguez-Garcia, M. Sanchez-Martin, J. Perez-Losada, P. A. Perez-Mancera, A. Sagrera-Aparisi, N. Gutierrez-Cianca, C. Cobaleda and I. Sanchez-Garcia
DOI: 10.2174/1568009013334214

Order Reprints Order Eprints

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

Volume:1   Issue:2
Pp: 129-140
Sutapa Ghosh, Xing-Ping Liu, Yaguo Zheng and Fatih M. Uckun
DOI: 10.2174/1568009013334188

Order Reprints Order Eprints